After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
RLAY belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Relay Therapeutics Inc is $490.33M. A total of 1.12 million shares were traded on the day, compared to an average of 2.61M shares.
In the most recent transaction, Rahmer Peter sold 10,739 shares of RLAY for 3.00 per share on Apr 30 ’25. After the transaction, the insider now owns 390,081 company shares. In a previous transaction on Apr 28 ’25, Rahmer Peter sold 1,364 shares at 3.17 per share. RLAY shares that the insider owns now total 400,820.
Among the insiders who sold shares, Catinazzo Thomas disposed of 12,943 shares on Apr 30 ’25 at a per-share price of $3.00. This resulted in the Chief Financial Officer holding 355,376 shares of RLAY after the transaction. In another insider transaction, Catinazzo Thomas sold 3,558 shares at $3.23 per share on Apr 29 ’25. Company shares held by the Chief Financial Officer now total 368,319.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, RLAY has a high of $10.72 and a low of $1.77.
As of this writing, RLAY has an earnings estimate of -$0.47 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.37 per share and a lower estimate of -$0.53.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $4.23, while its Total Shareholder’s Equity was $897.81M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
